[The second half of de novo synthetic pathway of IMP and conversion of IMP to AMP].
Oka
Jun
J
National Institute of Health and Nutrition.
D000249:Adenosine Monophosphate / Q000096:biosynthesis*; D000264:Adenylosuccinate Lyase / Q000172:deficiency / Q000502:physiology; D000265:Adenylosuccinate Synthase / Q000502:physiology; D000818:Animals; D002384:Catalysis; D006801:Humans; D019877:Hydroxymethyl and Formyl Transferases / Q000502:physiology; D007291:Inosine Monophosphate / Q000096:biosynthesis* / Q000378:metabolism; D009097:Multienzyme Complexes / Q000502:physiology; D009709:Nucleotide Deaminases / Q000502:physiology; D051027:Phosphoribosylaminoimidazolecarboxamide Formyltransferase; D011685:Purine Nucleotides / Q000096:biosynthesis*
D009097:Multienzyme Complexes; D011685:Purine Nucleotides; C113120:inosine monophosphate synthase; D007291:Inosine Monophosphate; D000249:Adenosine Monophosphate; D019877:Hydroxymethyl and Formyl Transferases; D051027:Phosphoribosylaminoimidazolecarboxamide Formyltransferase; D009709:Nucleotide Deaminases; D000264:Adenylosuccinate Lyase; D000265:Adenylosuccinate Synthase